Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02443337
Title A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Southern Cancer Center, P.C. Mobile Alabama 36608 United States Details
Ironwood Cancer & Research Centers Chandler Arizona 85224 United States Details
Comprehensive Cancer Care and Research Institute of Colorado Englewood Colorado 80113 United States Details
Florida Cancer Specialists Fort Myers Florida 33916 United States Details
Florida Hospital Cancer Institute Orlando Florida 32804 United States Details
Florida Cancer Specialists Saint Petersburg Florida 33705 United States Details
Palm Beach Cancer Institute West Palm Beach Florida 33401 United States Details
Research Medical Center Kansas City Missouri 64132 United States Details
Oncology Hematology Care Inc. Cincinnati Ohio 45242 United States Details
Chattanooga Oncology Hematology Chattanooga Tennessee 37404 United States Details
SMO Sarah Cannon Research Inst. Nashville Tennessee 37203 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Center for Cancer and Blood Disorders Fort Worth Texas 76104 United States Details
University of Virginia Health Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field